IRIS Accounts Production v23.1.5.20 08651822 director 1.3.22 28.2.23 28.2.23 false true false false false false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh086518222022-02-28086518222023-02-28086518222022-03-012023-02-28086518222021-02-28086518222021-03-012022-02-28086518222022-02-2808651822ns15:EnglandWales2022-03-012023-02-2808651822ns14:PoundSterling2022-03-012023-02-2808651822ns10:Director12022-03-012023-02-2808651822ns10:PrivateLimitedCompanyLtd2022-03-012023-02-2808651822ns10:Micro-entities2022-03-012023-02-2808651822ns10:AuditExempt-NoAccountantsReport2022-03-012023-02-2808651822ns10:FullAccounts2022-03-012023-02-280865182212022-03-012023-02-2808651822ns5:CurrentFinancialInstruments2023-02-2808651822ns5:CurrentFinancialInstruments2022-02-2808651822ns5:Non-currentFinancialInstruments2023-02-2808651822ns5:Non-currentFinancialInstruments2022-02-2808651822ns10:RegisteredOffice2022-03-012023-02-28086518221ns10:Director12022-02-28086518221ns10:Director12021-02-28086518221ns10:Director12022-03-012023-02-28086518221ns10:Director12021-03-012022-02-28086518221ns10:Director12023-02-28086518221ns10:Director12022-02-28
REGISTERED NUMBER: 08651822 (England and Wales)



















UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 28 FEBRUARY 2023

FOR

HC PHARMA LIMITED

HC PHARMA LIMITED (REGISTERED NUMBER: 08651822)






CONTENTS OF THE FINANCIAL STATEMENTS
for the Year Ended 28 February 2023




Page

Balance Sheet 1


HC PHARMA LIMITED (REGISTERED NUMBER: 08651822)

BALANCE SHEET
28 February 2023

2023 2022
£    £    £    £   
FIXED ASSETS 836,137 734,062

CURRENT ASSETS 324,975 393,827

CREDITORS
Amounts falling due within one year (245,811 ) (209,714 )
NET CURRENT ASSETS 79,164 184,113
TOTAL ASSETS LESS CURRENT
LIABILITIES

915,301

918,175

CREDITORS
Amounts falling due after more than one year 502,233 593,727
NET ASSETS 413,068 324,448

CAPITAL AND RESERVES 413,068 324,448

NOTES TO THE FINANCIAL STATEMENTS

1. STATUTORY INFORMATION

Hc Pharma Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 08651822

Registered office: 141 Cropthorne Road
Shirley
Solihull
West Midlands
B90 3JL

2. AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was 8 (2022 - 8 ) .

HC PHARMA LIMITED (REGISTERED NUMBER: 08651822)

BALANCE SHEET - continued
28 February 2023

NOTES TO THE FINANCIAL STATEMENTS

3. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 28 February 2023 and 28 February 2022:

2023 2022
£    £   
Hinesh Chauhan
Balance outstanding at start of year (136,724 ) (133,911 )
Amounts advanced 181,199 34,056
Amounts repaid (30,687 ) (36,869 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 13,788 (136,724 )

Dividends issued during the year = £29,000 (£29,000 in 2022)



The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 28 February 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 28 February 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the director and authorised for issue on 27 November 2023 and were signed by:





Hinesh Chauhan - Director